NCT01648855View on ClinicalTrials.gov

Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2016

Conditions
Preterm BirthIntra-uterine Growth RestrictionMaternal PreeclampsiaBronchopulmonary Dysplasia
Interventions
OTHER

Biological samples

To measure the levels of sFlt1, angiogenic and antiangiogenic factors at birth in maternal blood, umbilical cord blood and in the amniotic fluid

Trial Locations (1)

75014

Cochin Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01648855 - Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn | Biotech Hunter | Biotech Hunter